DDIT4 and prostate carcinoma: Although, the experiment with REDD1 MEFs cannot be extrapolated to prostate cancer cells but using REDD1+/+ and REDD1−/− cells, modest resistance to cell death is observed in REDD1−/− cells as observed by cleaved-PARP and cell growth inhibition assays.